6 Recruiting Metastatic Melanoma Phase 1 Clinical Trials
Active phase 1 studies for metastatic melanoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Metastatic Melanoma studiesPhase 1 Studies for Metastatic Melanoma
🔵 Active, Not Recruiting Phase1
Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid Malignancies
📍 Mayo Clinic in Florida — Jacksonville, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1
A Study of LN-144 in People With Metastatic Melanoma to the Brain
📍 Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase1
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
📍 University of Iowa — Iowa City, Iowa
View Study & Checklist ➔ 🟢 Recruiting Phase1
IL-17 Blockade to Decrease irAEs (REPLAY)
📍 Duke University Health System — Durham, North Carolina
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Hepzato Kit and Opdualag for Metastatic Melanoma and Liver Metastasis
📍 UW Hospital and Clinics — Madison, Wisconsin
View Study & Checklist ➔